Massive Bio Partnership Advances AI Precision Medicine and Oncology Research Across the Americas
Health technology enterprise Massive Bio collaborates with regional study group GELL under the Massive Bio Partnership to expand clinical trial access and medical education. News About Massive Bio Partnership Oncology artificial intelligence developer Massive Bio announced a strategic alliance with the Latin American Study Group on Lymphoproliferative Disorders (GELL). The partnership links GELL’s network of…